Abstract
A large proportion of psychiatric patients in developing countries live in rural areas. The practice of psychopharmacology in rural settings is limited by availability, accessibility, and affordability of the medications. Sometimes, second-line medications may need to be prescribed when the first-line medications are not available. Also, cultural factors as well as other practical realities may constrain the use of medications. Therefore, evidence-based medicine may need to be tailored to suit to these ground realities.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Aman MG, Collier-Crespin A, Lindsay RL (2000) Pharmacotherapy of disorders in mental retardation. Eur Child Adolesc Psychiatry 9(Suppl 1):S98–S107
Andrade C (2016) Antipsychotic drugs in schizophrenia: relative effects in patients with and without treatment resistance. J Clin Psychiatry 77:e1656–e1660. https://doi.org/10.4088/JCP.16f11328
Andrade C (2017a) Ketamine for depression, 1: clinical summary of issues related to efficacy, adverse effects, and mechanism of action. J Clin Psychiatry 78:e415–e419. https://doi.org/10.4088/JCP.17f11567
Andrade C (2017b) Ketamine for depression, 4: in what dose, at what rate, by what route, for how long, and at what frequency? J Clin Psychiatry 78:e852–e857. https://doi.org/10.4088/JCP.17f11738
Andrade C, Kumar CB, Surya S (2013) Cardiovascular mechanisms of SSRI drugs and their benefits and risks in ischemic heart disease and heart failure. Int Clin Psychopharmacol 28:145–155. https://doi.org/10.1097/YIC.0b013e32835d735d
Bloch MH, McGuire J, Landeros-Weisenberger A, Leckman JF, Pittenger C (2010) Meta-analysis of the dose-response relationship of SSRI in obsessive-compulsive disorder. Mol Psychiatry 15:850–855. https://doi.org/10.1038/mp.2009.50
Cahill K, Lindson-Hawley N, Thomas KH, Fanshawe TR, Lancaster T (2016) Nicotine receptor partial agonists for smoking cessation. Cochrane Database Syst Rev 5:CD006103. https://doi.org/10.1002/14651858.CD006103.pub7
Calandre EP, Rico-Villademoros F, Slim M (2015) An update on pharmacotherapy for the treatment of fibromyalgia. Expert Opin Pharmacother 16:1347–1368. https://doi.org/10.1517/14656566.2015.1047343
Castiglione F, Albersen M, Hedlund P, Gratzke C, Salonia A, Giuliano F (2016) Current pharmacological management of premature ejaculation: a systematic review and meta-analysis. Eur Urol 69:904–916. https://doi.org/10.1016/j.eururo.2015.12.028
Chew-Graham CA, Heyland S, Kingstone T, Shepherd T, Buszewicz M, Burroughs H et al (2017) Medically unexplained symptoms: continuing challenges for primary care. Br J Gen Pract 67:106–107. https://doi.org/10.3399/bjgp17X690785
Cipriani A, Furukawa TA, Salanti G, Geddes JR, Higgins JP, Churchill R et al (2009) Comparative efficacy and acceptability of 12 new-generation antidepressants: a multiple-treatments meta-analysis. Lancet 373:746–758. https://doi.org/10.1016/S0140-6736(09)60046-5
Cipriani A, Barbui C, Salanti G, Rendell J, Brown R, Stockton S et al (2011) Comparative efficacy and acceptability of antimanic drugs in acute mania: a multiple-treatments meta-analysis. Lancet 378:1306–1315. https://doi.org/10.1016/S0140-6736(11)60873-8
Colijn MA, Nitta BH, Grossberg GT (2015) Psychosis in later life: a review and update. Harv Rev Psychiatry 23:354–367. https://doi.org/10.1097/HRP.0000000000000068
Donoghue K, Elzerbi C, Saunders R, Whittington C, Pilling S, Drummond C (2015) The efficacy of acamprosate and naltrexone in the treatment of alcohol dependence, Europe versus the rest of the world: a meta-analysis. Addiction 110:920–930. https://doi.org/10.1111/add.12875
Finley PR (2016) Drug interactions with lithium: an update. Clin Pharmacokinet 55:925–941. https://doi.org/10.1007/s40262-016-0370-y
Fleming J, Chetty M (2005) Psychotropic drug interactions with valproate. Clin Neuropharmacol 28:96–101
Groenman AP, Schweren LJ, Dietrich A, Hoekstra PJ (2017) An update on the safety of psychostimulants for the treatment of attention-deficit/hyperactivity disorder. Expert Opin Drug Saf 16:455–464. https://doi.org/10.1080/14740338.2017.1301928
Guglielmo R, Martinotti G, Quatrale M, Ioime L, Kadilli I, Di Nicola M et al (2015) Topiramate in alcohol use disorders: review and update. CNS Drugs 29:383–395. https://doi.org/10.1007/s40263-015-0244-0
Hawksworth DJ, Burnett AL (2015) Pharmacotherapeutic management of erectile dysfunction. Clin Pharmacol Ther 98:602–610. https://doi.org/10.1002/cpt.261
Hughes JR, Stead LF, Hartmann-Boyce J, Cahill K, Lancaster T (2014) Antidepressants for smoking cessation. Cochrane Database Syst Rev 1:CD000031. https://doi.org/10.1002/14651858.CD000031.pub4
Kales HC, Gitlin LN, Lyketsos CG, Detroit Expert Panel on Assessment and Management of Neuropsychiatric Symptoms of Dementia (2014) Management of neuropsychiatric symptoms of dementia in clinical settings: recommendations from a multidisciplinary expert panel. J Am Geriatr Soc 62:762–769. https://doi.org/10.1111/jgs.12730
Kolla BP, Mansukhani MP, Schneekloth T (2011) Pharmacological treatment of insomnia in alcohol recovery: a systematic review. Alcohol Alcohol 46:578–585. https://doi.org/10.1093/alcalc/agr073
Leucht S, Cipriani A, Spineli L, Mavridis D, Orey D, Richter F et al (2013) Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: a multiple-treatments meta-analysis. Lancet 382:951–962. https://doi.org/10.1016/S0140-6736(13)60733-3
Loane C, Politis M (2012) Buspirone: what is it all about? Brain Res 1461:111–118. https://doi.org/10.1016/j.brainres.2012.04.032
Maisel NC, Blodgett JC, Wilbourne PL, Humphreys K, Finney JW (2013) Meta-analysis of naltrexone and acamprosate for treating alcohol use disorders: when are these medications most helpful? Addiction 108:275–293. https://doi.org/10.1111/j.1360-0443.2012.04054.x
Meagher DJ, McLoughlin L, Leonard M, Hannon N, Dunne C, O’Regan N (2013) What do we really know about the treatment of delirium with antipsychotics? Ten key issues for delirium pharmacotherapy. Am J Geriatr Psychiatry 21:1223–1238. https://doi.org/10.1016/j.jagp.2012.09.008
Moretti A, Gorini A, Villa RF (2011) Pharmacotherapy and prevention of vascular dementia. CNS Neurol Disord Drug Targets 10:370–390
Pompili M, Baldessarini RJ, Forte A, Erbuto D, Serafini G, Fiorillo A et al (2016) Do atypical antipsychotics have antisuicidal effects? A hypothesis-generating overview. Int J Mol Sci 17:E1700. https://doi.org/10.3390/ijms17101700
Rackley S, Bostwick JM (2012) Depression in medically ill patients. Psychiatr Clin N Am 35:231–247. https://doi.org/10.1016/j.psc.2011.11.001
Russo A, Capogrosso P, Ventimiglia E, La Croce G, Boeri L, Montorsi F et al (2016) Efficacy and safety of dapoxetine in treatment of premature ejaculation: an evidence-based review. Int J Clin Pract 70:723–733. https://doi.org/10.1111/ijcp.12843
Severus E, Taylor MJ, Sauer C, Pfennig A, Ritter P, Bauer M et al (2014) Lithium for prevention of mood episodes in bipolar disorders: systematic review and meta-analysis. Int J Bipolar Disord 2:15. https://doi.org/10.1186/s40345-014-0015-8
Singh AN, Matson JL, Cooper CL, Dixon D, Sturmey P (2005) The use of risperidone among individuals with mental retardation: clinically supported or not? Res Dev Disabil 26:203–218. https://doi.org/10.1016/j.ridd.2004.07.001
Teslyar P, Stock VM, Wilk CM, Camsari U, Ehrenreich MJ, Himelhoch S (2013) Prophylaxis with antipsychotic medication reduces the risk of post-operative delirium in elderly patients: a meta-analysis. Psychosomatics 54:124–131. https://doi.org/10.1016/j.psym.2012.12.004
Tsoi DT, Porwal M, Webster AC (2010) Efficacy and safety of bupropion for smoking cessation and reduction in schizophrenia: systematic review and meta-analysis. Br J Psychiatry 196:346–353. https://doi.org/10.1192/bjp.bp.109.066019
Wong CW (2016) Pharmacotherapy for dementia: a practical approach to the use of cholinesterase inhibitors and memantine. Drugs Aging 33:451–460. https://doi.org/10.1007/s40266-016-0372-3
Yeung WF, Chung KF, Yung KP, Ng TH (2015) Doxepin for insomnia: a systematic review of randomized placebo-controlled trials. Sleep Med Rev 19:75–83. https://doi.org/10.1016/j.smrv.2014.06.001
Zhou X, Ravindran AV, Qin B, Del Giovane C, Li Q, Bauer M et al (2015) Comparative efficacy, acceptability, and tolerability of augmentation agents in treatment-resistant depression: systematic review and network meta-analysis. J Clin Psychiatry 76:e487–e498. https://doi.org/10.4088/JCP.14r09204
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Nature Singapore Pte Ltd.
About this entry
Cite this entry
Praharaj, S.K., Andrade, C. (2019). Psychopharmacology in Rural Settings. In: Chaturvedi, S. (eds) Mental Health and Illness in Rural World. Mental Health and Illness Worldwide. Springer, Singapore. https://doi.org/10.1007/978-981-10-0751-4_17-1
Download citation
DOI: https://doi.org/10.1007/978-981-10-0751-4_17-1
Received:
Accepted:
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-10-0751-4
Online ISBN: 978-981-10-0751-4
eBook Packages: Springer Reference Behavioral Science and PsychologyReference Module Humanities and Social SciencesReference Module Business, Economics and Social Sciences